Literature DB >> 17082827

Expert synthesis of the literature to support critical care decision making.

Rebecca N Jerome1, Randolph A Miller.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17082827      PMCID： PMC1629446     

Source DB:  PubMed          Journal:  J Med Libr Assoc        ISSN： 1536-5050


× No keyword cloud information.
  13 in total

1.  The medical review article revisited: has the science improved?

Authors:  F A McAlister; H D Clark; C van Walraven; S E Straus; F M Lawson; D Moher; C D Mulrow
Journal:  Ann Intern Med       Date:  1999-12-21       Impact factor: 25.391

2.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

Review 3.  Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.

Authors:  Matthew E Falagas; Sofia K Kasiakou
Journal:  Clin Infect Dis       Date:  2005-03-22       Impact factor: 9.079

4.  Using intrathecal colistin for multidrug resistant shunt infection.

Authors:  H Sueke; H Marsh; A Dhital
Journal:  Br J Neurosurg       Date:  2005-02       Impact factor: 1.596

5.  Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.

Authors:  Sofia K Kasiakou; Argyris Michalopoulos; Elpidoforos S Soteriades; George Samonis; George J Sermaides; Matthew E Falagas
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 6.  Clinical and economic consequences of ventilator-associated pneumonia: a systematic review.

Authors:  Nasia Safdar; Cameron Dezfulian; Harold R Collard; Sanjay Saint
Journal:  Crit Care Med       Date:  2005-10       Impact factor: 7.598

7.  Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

Authors:  J Garnacho-Montero; C Ortiz-Leyba; F J Jiménez-Jiménez; A E Barrero-Almodóvar; J L García-Garmendia; M Bernabeu-WittelI; S L Gallego-Lara; J Madrazo-Osuna
Journal:  Clin Infect Dis       Date:  2003-04-14       Impact factor: 9.079

8.  Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study.

Authors:  Rosa Reina; Elisa Estenssoro; Gabriela Sáenz; Héctor S Canales; Romina Gonzalvo; Gabriela Vidal; Gustavo Martins; Andrea Das Neves; Oscar Santander; Carlos Ramos
Journal:  Intensive Care Med       Date:  2005-06-28       Impact factor: 17.440

Review 9.  Toxicity of polymyxins: a systematic review of the evidence from old and recent studies.

Authors:  Matthew E Falagas; Sofia K Kasiakou
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

10.  Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.

Authors:  Argyris Michalopoulos; Sofia K Kasiakou; Zefi Mastora; Kostas Rellos; Anastasios M Kapaskelis; Matthew E Falagas
Journal:  Crit Care       Date:  2005-01-06       Impact factor: 9.097
View more
  3 in total

1.  Using the literature to evaluate diagnostic tests: amylase or lipase for diagnosing acute pancreatitis?

Authors:  Julie M Beauregard; Jennifer A Lyon; Corey Slovis
Journal:  J Med Libr Assoc       Date:  2007-04

2.  Synthesis of informatics literature to support institutional policy statement development.

Authors:  Taneya Y Koonce; Nila A Sathe; Dario A Giuse; Jim Jirjis
Journal:  J Med Libr Assoc       Date:  2008-01

3.  Bringing evidence to practice: a team approach to teaching skills required for an informationist role in evidence-based clinical and public health practice.

Authors:  Kathleen Burr Oliver; Prudence Dalrymple; Harold P Lehmann; Deborah Ann McClellan; Karen A Robinson; Claire Twose
Journal:  J Med Libr Assoc       Date:  2008-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.